Advances in Neoadjuvant Therapy for Cutaneous Melanoma
10.11735/j.issn.1004-0242.2024.12.A011
- VernacularTitle:皮肤黑色素瘤新辅助治疗的研究进展
- Author:
Donglin KANG
1
;
Lianjun ZHAO
;
Yu REN
;
Xinyu SU
;
Zhengyun ZOU
Author Information
1. 南京医科大学附属鼓楼临床医学院肿瘤中心,江苏南京 210008
- Keywords:
cutaneous melanoma;
neoadjuvant therapy;
immunotherapy;
targeted therapy;
adju-vant therapy
- From:
China Cancer
2024;33(12):1033-1041
- CountryChina
- Language:Chinese
-
Abstract:
Cutaneous melanoma is a malignant skin cancer with a poor prognosis.However,re-cent advances in immune checkpoint blockade and targeted therapy have significantly improved outcomes in advanced-stage resectable melanoma,which have made neoadjuvant therapy a viable option for melanoma patients.Currently,several relevant clinical trials on neoadjuvant therapy have achieved significant results.This paper reviews the recent advances in neoadjuvant therapy for cutaneous melanoma,focusing on the selection of neoadjuvant therapy,subsequent surgical considerations after neoadjuvant therapy,prognostic indicators,and baseline biomarkers.
